Science4Data Article Insights

https://www.ishares.com/us/insights/etf-trends/the-megatrend-approach

Tech and healthcare innovation: The megatrend approach

2020-06-10 15:10:00, , BlackRock

Content Categorization
/Business & Industrial/Pharmaceuticals & Biotech

Word Count:
1189

Words/Sentence:
30

Reading Time:
11.89 min

Reading Quality:
Advanced

Readability:
16th or higher

Media Sentiment
Proprietary sentiment analysis on both the headline and body text of the article. Sentiment scores range from -1 (very negative sentiment) to 1 (very positive sentiment).
RCS Analysis
Relative scoring for Risk, Crisis, and Security language within the article.
Risk Score
Scoring based on the composite risk, security and crisis language within an article compared to a baseline of historic analysis across thousands of diverse articles.
PESTEL Scope
Analysis of article orientation across the PESTEL macro-environmental analysis framework. Learn more about PESTEL.
Entity Word Cloud
Key people, places, organizations and events referenced in the article, weighted by frequency and colored based on contextual sentiment.
Auto Summary
Condensing key features of the article based on salience analysis. Helpful for “gisting” the article in a time crunch.

Allocations are subject to change.

In contrast, megatrend tech and healthcare indexes seek to target innovation, with exposure across geographies, sectors and market caps, beyond large-caps.

However, for those interested in exposure to tech and healthcare innovation, we think investment vehicles focused on these megatrends offer a potential alternative versus traditional sector benchmarks.

Specifically, the COVID-19 pandemic is accelerating the focus on longer-term innovations in technology and healthcare.

We see tech and healthcare innovation at the forefront of future growth and believe investors should consider long-term allocations to related megatrends, which take a view on the powerful, long-term economic and societal changes that are shaping our world.

COVID-19 uncertainty accelerates megatrends in healthcare and technology

Concerns surrounding the near-term economic impact of the COVID-19 pandemic have created a sense of uncertainty among investors looking to allocate capital.

Indeed, the Brookings Institute estimated global Pharmaceutical R&D spending of $156.7bn as of 2016.5

As with technology, COVID-19 has increased investor attention in next generation healthcare treatments.

Keywords
Thematic, Global, Trend, Outperform, global, Developed, Cybersecurity, North America, Megatrend ETFs, ETFs, AI, Technology, Healthcare, Equity, Megatrends, Investment

Interested in Learning More?

Article Analysis is at the foundation of powerful media monitoring and insights. Learn what you can build with powerful curated search engines, real-time listening and trend analysis on the topics, markets and companies critical to your organization.